Gut microbiota analysis may help prevent the more serious effects of COVID-19. With this premise, Microviable seeks funding to design a predictive model and open the possibility of designing treatments from Spain.
17
Jun, 2020
20
May, 2020
Towards controlling the “second brain” that inhabits your intestines
View more at “La Voz de Asturias”
Microviable Therapeutics offers the possibility of performing a microbiota transplant more comfortably and even storing the microbiota for future therapeutic uses.
17
Mar, 2020
Microviable Therapeutics pioneer in the field of microbiota.
El Comercio (Diario de Asturias), highlights Microviable’s activity in “the long-term isolation and storage of the microbiota under viable conditions, the analysis of its composition and, finally, the development of microbiome-based therapies. The first two business lines of Microviable, the collection of faecal samples guaranteeing the anaerobiosis (absence of oxygen) conditions with the patented GutAlive device, and the storage service, are already fully active. The GutAlive kit sales already reach five countries and more than half of the researchers or clinicians who know it, want to try it.
16
Sep, 2019
Microviable Therapeutics pioneers the microbiota storage
During the last week, the media had covered the exclusive service of intestinal microbiota storage that we offer.